Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial Authors: Elizabeth A. R. Garfinkle, Renzo Perales-Linares, Ryan C. Gimple, Alexandra J. Livingstone, Kaleigh F. Roberts, Omar H. Butt, S. Peter Goedegebuure, Michael D. McLellan, Gue Su Chang, Jasreet Hundal, Jian Yan, Jaye B. Navarro, Sophia A. Paxton, Srestha Chattopadhyay, Neil Cooch, Alfredo Perales-Puchalt, Konstantina Stavroulaki, Sarah Rochestie, Joann Peters, Beth Junker, Jian L. Campian, Milan G. Chheda, Michael R. Chicoine, Albert H. Kim, Jon T. Willie, Gregory J. Zipfel, Joshua L. Dowling, Christopher A. Miller, Obi L. Griffith, Malachi Griffith, William E. Gillanders, Katherine E. Miller, Elaine R. Mardis, Niranjan Y. Sardesai, Gavin P. Dunn, Tanner M. Johanns Published: 2026 Correction to: Nature Cancer https://doi.org/10.1038/s43018-026-01163-w, published online 12 May 2026. In the version of the article initially published, in the top-left graph of Fig. 3b, the y-axis label was “CD4+CD69+ (%, delta)” but should have been “CD8+CD69+ (%, delta)”. In the top-right box of Fig. 5d, the label “Post-GNOS-PV01” should have read “Pre-GNOS-PV01”. These corrections have been made to the HTML and PDF versions of the article.